DOCSLIB.ORG

Acetate Supplementation Reduces Disease Progression, Alters Cns

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Acetate Supplementation Reduces Disease Progression, Alters Cns University of North Dakota UND Scholarly Commons Theses and Dissertations Theses, Dissertations, and Senior Projects January 2017 Acetate Supplementation Reduces Disease Progression, Alters Cns And Myelin Lipid Content, And Influences Cns And Myelin Protein Content In Mice Subjected To Experimental Autoimmune Encephalomyelitis Amber C. Chevalier Follow this and additional works at: https://commons.und.edu/theses Recommended Citation Chevalier, Amber C., "Acetate Supplementation Reduces Disease Progression, Alters Cns And Myelin Lipid Content, And Influences Cns And Myelin Protein Content In Mice Subjected To Experimental Autoimmune Encephalomyelitis" (2017). Theses and Dissertations. 2186. https://commons.und.edu/theses/2186 This Dissertation is brought to you for free and open access by the Theses, Dissertations, and Senior Projects at UND Scholarly Commons. It has been accepted for inclusion in Theses and Dissertations by an authorized administrator of UND Scholarly Commons. For more information, please contact [email protected]. ACETATE SUPPLEMENTATION REDUCES DISEASE PROGRESSION, ALTERS CNS AND MYELIN LIPID CONTENT, AND INFLUENCES CNS AND MYELIN PROTEIN CONTENT IN MICE SUBJECTED TO EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS By Amber Christine Chevalier Bachelor of Arts, Concordia College, 2012 Dissertation Submitted to the Graduate Faculty of the University of North Dakota In partial fulfillment of the requirements For the degree of Doctor of Philosophy Grand Forks, North Dakota December 2017 Copyright 2017 Amber Chevalier ii PERMISSION Title: Acetate Supplementation Reduces Disease Progression, Alters CNS and Myelin Lipid Content, and Influences CNS and Myelin Protein Content in Mice Subjected to Experimental Autoimmune Encephalomyelitis Department: Pharmacology, Physiology, and Therapeutics Degree: Doctor of Philosophy In presenting this dissertation in partial fulfillment of the requirements for a graduate degree from the University of North Dakota, I agree that the library of this University shall make it freely available for inspection. I further agree that permission for extensive copying for scholarly purpose may be granted by the professor who supervised by dissertation work or, in his absence, by the Chairperson of the department or the dean of the School of Graduate Studies. It is understood that any copying or publication or to the use of this dissertation or part thereof for financial gain shall not be allowed without my written permission. It is also understood that due recognition shall be given to me and to the University of North Dakota in any scholarly use which may be made of any material in my dissertation. Amber Christine Chevalier December, 2017 iv TABLE OF CONTENTS LIST OF FIGURES ........................................................................................................... ix LIST OF TABLES ............................................................................................................. xi ACKNOWLEDGEMENTS .............................................................................................. xii ABSTRACT ..................................................................................................................... xiii CHAPTER I. INTRODUCTION .......................................................................................1 Multiple Sclerosis ............................................................................1 Animal Models Of Multiple Sclerosis .................................4 Current Available Therapies for Multiple Sclerosis ..........10 Gaps in Knowledge ............................................................15 Lipid Synthesis, Lipid Breakdown, and Myelin Lipid Composition .......................................................................17 Glyceryl Triacetate.............................................................23 Overview of Dissertation ...................................................26 II. METHODS ................................................................................................28 Materials ........................................................................................28 Induction of EAE and Treatment .......................................29 Myelin Staining ..................................................................30 Behavioral Testing .............................................................31 Total Spinal Cord and Brain Lipid Extraction ...................31 v Myelin Brain Lipid Extraction ...........................................32 Thin Layer Chromatography..............................................33 Quantifying Phospholipid Content ....................................34 Quantifying Ganglioside Content ......................................34 Quantifying Esterified Fatty Acid Content ........................35 Quantifying Cholesterol and Cholesteryl Ester Content ....35 Protein Isolation .................................................................36 Total Protein Determination ..............................................36 Western Blot Analysis .......................................................36 Statistical Analysis .............................................................38 III. STUDY I ....................................................................................................39 Increasing Acetyl-CoA Metabolism Attenuates Injury and Alters Spinal Cord Lipid Content in Mice Subjected to Experimental Autoimmune Encephalomyelitis ............................39 Acetate Supplementation Attenuates Clinical Symptoms in Mice Subjected to EAE ...............................39 EAE Results in a Reduction of Spinal Cord Phospholipid That Was Not Found in EAE Mice Treated With Glyceryl Triacetate ......................................41 Acetate Supplementation Modulates Spinal Cord Fatty Acid Content in Mice Subjected to EAE ..................43 Acetate Supplementation Prevents the Loss of Cholesterol in EAE Mice but Does Not Alter the EAE-Induced Decrease in Cholesteryl Esters ....................46 Acetate Supplementation Alters Spinal Cord Ganglioside Content in Mice Subjected to EAE................48 vi Acetate Supplementation Returns Cytosolic Phospholipase A2 (cPLA2) to Baseline but EAE and Treatment Did Not Alter Phospholipase C (PLC) Levels .................................50 Acetate Supplementation Slightly Increases FluoroMyelinTM Intensity in Mice Subjected to EAE .......52 IV. STUDY II...................................................................................................54 Increasing Acetyl-CoA Metabolism Alters Spinal Cord Phosphatidylinositol Palmitic and Oleic Acid Levels in Mice Subjected to Experimental Autoimmune Encephalomyelitis ..........................................................................54 Acetate Supplementation Alters Esterified Fatty Acid Content in Phosphatidylinositol of EAE Mice ..........54 V. STUDY III .................................................................................................56 Increasing Acetyl-CoA Metabolism Increases Total Brain and Brain Myelin Lipid Content in Mice Subjected to Experimental Autoimmune Encephalomyelitis ....................................................56 Acetate Supplementation Increases Total Brain Phospholipid Levels in Mice Subjected to EAE ................56 Acetate Supplementation Increases Brain Myelin Phosphatidylinositol in Mice Subjected to EAE ................58 Acetate Supplementation Had No Effect on Brain Cholesterol and Cholesteryl Ester Content in Mice Subjected to EAE ...............................................................60 Acetate Supplementation Increases Total Brain GD3 Ganglioside and Brain Myelin GM1 Ganglioside Content in Mice Subjected to EAE..................................................60 Acetate Supplementation Alters Spinal Cord Oligodendrocyte Myelin Glycoprotein and Phosphorylated Acetyl-CoA Carboxylase Protein Levels in Mice Subjected to EAE but Had No Effect on Alkylglycerone Phosphate Synthase and Acyl-CoA Synthetase ..................................64 VI. DISCUSSION ............................................................................................68 Overall Conclusion of Dissertation ................................................68 vii Multiple Sclerosis May Be a Metabolic Disorder..............69 An Inflammatory Stimulus May Be Necessary to Shift the Acetyl-CoA Pool into Producing Lipid .............................76 Therapeutic Window Where Glyceryl Triacetate May Benefit Demyelinating and Metabolic Disorders ..............81 Acetate’s Role in Oligodendrocyte Maturation, Differentiation, and Function .............................................82 The Significance of CNS Lipid Changes Due to EAE and Treatment Related to Myelin Structure, Function, and Stability .......................................................85 The Importance to Develop Therapies that Promote Lipid Synthesis and/or Reduce Lipid Breakdown to Treat Multiple Sclerosis ..............................................................88 Future Studies ....................................................................93 VII. SUMMARY .............................................................................................105 APPENDICES .................................................................................................................109 List of Abbreviations ...........................................................................................110 Copyright Clearance ............................................................................................115
Load more

Recommended publications
  • Peroxisomal Fatty Acid Beta-Oxidation in Relation to the Accumulation Of
    Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders. R J Wanders, … , A W Schram, J M Tager J Clin Invest. 1987;80(6):1778-1783. https://doi.org/10.1172/JCI113271. Research Article The peroxisomal oxidation of the long chain fatty acid palmitate (C16:0) and the very long chain fatty acids lignocerate (C24:0) and cerotate (C26:0) was studied in freshly prepared homogenates of cultured skin fibroblasts from control individuals and patients with peroxisomal disorders. The peroxisomal oxidation of the fatty acids is almost completely dependent on the addition of ATP, coenzyme A (CoA), Mg2+ and NAD+. However, the dependency of the oxidation of palmitate on the concentration of the cofactors differs markedly from that of the oxidation of lignocerate and cerotate. The peroxisomal oxidation of all three fatty acid substrates is markedly deficient in fibroblasts from patients with the Zellweger syndrome, the neonatal form of adrenoleukodystrophy and the infantile form of Refsum disease, in accordance with the deficiency of peroxisomes in these patients. In fibroblasts from patients with X-linked adrenoleukodystrophy the peroxisomal oxidation of lignocerate and cerotate is impaired, but not that of palmitate. Competition experiments indicate that in fibroblasts, as in rat liver, distinct enzyme systems are responsible for the oxidation of palmitate on the one hand and lignocerate and cerotate on the other hand. Fractionation studies indicate that in rat liver activation of cerotate and lignocerate to cerotoyl-CoA and lignoceroyl-CoA, respectively, occurs in two subcellular fractions, the endoplasmic reticulum and the peroxisomes but not in the mitochondria.
    [Show full text]
  • Newborn Screening for X-Linked Adrenoleukodystrophy: Information for Parents
    Newborn Screening for X-linked Adrenoleukodystrophy: Information for Parents Baby girl with ABCD1 gene mutation What is newborn screening? the symptoms of ALD during childhood. Rarely, some women who are carriers of ALD develop mild symptoms as adults. It Newborn screening involves laboratory testing on a small is important for your family to meet with a genetic counselor sample of blood collected from newborns’ heels. Every state to talk about the genetics of ALD and implications for other has a newborn screening program to identify infants with rare family members. disorders, which would not usually be detected at birth. Early diagnosis and treatment of these disorders often prevents Why do only boys have ALD? serious complications. Only boys have ALD because it is caused by a mutation in What is adrenoleukodystrophy (ALD)? a gene (ABCD1) on the X chromosome, called “X-linked inheritance.” Males only have one X chromosome so they have ALD is one of over 40 disorders included in newborn screening one ABCD1 gene. Males with a nonfunctioning ABCD1 gene in New York State. It is a rare genetic disorder. People with have ALD. Females have 2 X chromosomes, so they have two ALD are unable to breakdown a component of food called ABCD1 genes. Females with one ABCD1 gene mutation will very long chain fatty acids (VLCFA). If VLCFA are not broken be carriers. When a mother is a carrier of ALD, each son has a down, they build up in the body and cause symptoms. 50% chance of inheriting the disorder and each daughter has a 50% chance of being a carrier.
    [Show full text]
  • Sigma Fatty Acids, Glycerides, Oils and Waxes
    Sigma Fatty Acids, Glycerides, Oils and Waxes Library Listing – 766 spectra This library represents a material-specific subset of the larger Sigma Biochemical Condensed Phase Library relating to relating to fatty acids, glycerides, oils, and waxes found in the Sigma Biochemicals and Reagents catalog. Spectra acquired by Sigma-Aldrich Co. which were examined and processed at Thermo Fisher Scientific. The spectra include compound name, molecular formula, CAS (Chemical Abstract Service) registry number, and Sigma catalog number. Sigma Fatty Acids, Glycerides, Oils and Waxes Index Compound Name Index Compound Name 464 (E)-11-Tetradecenyl acetate 592 1-Monocapryloyl-rac-glycerol 118 (E)-2-Dodecenedioic acid 593 1-Monodecanoyl-rac-glycerol 99 (E)-5-Decenyl acetate 597 1-Monolauroyl-rac-glycerol 115 (E)-7,(Z)-9-Dodecadienyl acetate 599 1-Monolinolenoyl-rac-glycerol 116 (E)-8,(E)-10-Dodecadienyl acetate 600 1-Monolinoleoyl-rac-glycerol 4 (E)-Aconitic acid 601 1-Monomyristoyl-rac-glycerol 495 (E)-Vaccenic acid 598 1-Monooleoyl-rac-glycerol 497 (E)-Vaccenic acid methyl ester 602 1-Monopalmitoleoyl-rac-glycerol 98 (R)-(+)-2-Chloropropionic acid methyl 603 1-Monopalmitoyl-rac-glycerol ester 604 1-Monostearoyl-rac-glycerol; 1- 139 (Z)-11-Eicosenoic anhydride Glyceryl monosterate 180 (Z)-11-Hexadecenyl acetate 589 1-O-Hexadecyl-2,3-dipalmitoyl-rac- 463 (Z)-11-Tetradecenyl acetate glycerol 181 (Z)-3-Hexenyl acetate 588 1-O-Hexadecyl-rac-glycerol 350 (Z)-3-Nonenyl acetate 590 1-O-Hexadecyl-rac-glycerol 100 (Z)-5-Decenyl acetate 591 1-O-Hexadecyl-sn-glycerol
    [Show full text]
  • Peroxisome Biogenesis Disorders ⁎ Steven J
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1763 (2006) 1733–1748 www.elsevier.com/locate/bbamcr Review Peroxisome biogenesis disorders ⁎ Steven J. Steinberg a,b, , Gabriele Dodt c, Gerald V. Raymond a,b, Nancy E. Braverman d, Ann B. Moser a,b, Hugo W. Moser a,b a Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA b Kennedy Krieger Institute, Baltimore, MD, USA c Interfakultäres Institut für Biochemie, Eberhard Karls Universität, Tübingen, Germany d Department of Pediatrics and Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA Received 25 May 2006; received in revised form 5 September 2006; accepted 6 September 2006 Available online 14 September 2006 Abstract Defects in PEX genes impair peroxisome assembly and multiple metabolic pathways confined to this organelle, thus providing the biochemical and molecular bases of the peroxisome biogenesis disorders (PBD). PBD are divided into two types—Zellweger syndrome spectrum (ZSS) and rhizomelic chondrodysplasia punctata (RCDP). Biochemical studies performed in blood and urine are used to screen for the PBD. DNA testing is possible for all of the disorders, but is more challenging for the ZSS since 12 PEX genes are known to be associated with this spectrum of PBD. In contrast, PBD-RCDP is associated with defects in the PEX7 gene alone. Studies of the cellular and molecular defects in PBD patients have contributed significantly to our understanding of the role of each PEX gene in peroxisome assembly. © 2006 Elsevier B.V.
    [Show full text]
  • Harvest Season Significantly Influences the Fatty Acid
    biology Article Harvest Season Significantly Influences the Fatty Acid Composition of Bee Pollen Saad N. Al-Kahtani 1 , El-Kazafy A. Taha 2,* , Soha A. Farag 3, Reda A. Taha 4, Ekram A. Abdou 5 and Hatem M Mahfouz 6 1 Arid Land Agriculture Department, College of Agricultural Sciences & Foods, King Faisal University, P.O. Box 400, Al-Ahsa 31982, Saudi Arabia; [email protected] 2 Department of Economic Entomology, Faculty of Agriculture, Kafrelsheikh University, Kafrelsheikh 33516, Egypt 3 Department of Animal and Poultry Production, Faculty of Agriculture, University of Tanta, Tanta 31527, Egypt; [email protected] 4 Agricultural Research Center, Bee Research Department, Plant Protection Research Institute, Dokki, Giza, Egypt; [email protected] 5 Agricultural Research Center, Plant Protection Research Institute, Dokki, Giza, Egypt; [email protected] 6 Department of Plant Production, Faculty of Environmental Agricultural Sciences, Arish University, Arish 45511, Egypt; [email protected] * Correspondence: elkazafi[email protected] Simple Summary: Harvesting pollen loads collected from a specific botanical origin is a complicated process that takes time and effort. Therefore, we aimed to determine the optimal season for harvesting pollen loads rich in essential fatty acids (EFAs) and unsaturated fatty acids (UFAs) from the Al- Ahsa Oasis in eastern Saudi Arabia. Pollen loads were collected throughout one year, and the Citation: Al-Kahtani, S.N.; tested samples were selected during the top collecting period in each season. Lipids and fatty acid Taha, E.-K.A.; Farag, S.A.; Taha, R.A.; composition were determined. The highest values of lipids concentration, linolenic acid (C ), Abdou, E.A.; Mahfouz, H.M Harvest 18:3 Season Significantly Influences the stearic acid (C18:0), linoleic acid (C18:2), arachidic acid (C20:0) concentrations, and EFAs were obtained Fatty Acid Composition of Bee Pollen.
    [Show full text]
  • Control of Differentiation of a Mammary Cell Line by Lipids
    Proc. Natl. Acad. Sci. USA Vol. 77, No. 3, pp. 1551-1555, March 1980 Cell Biology Control of differentiation of a mammary cell line by lipids (domes/tumor promoters/fatty acids/lysolecithins) RENATO DULBECCO*, MAURO BOLOGNAt, AND MICHAEL UNGER The Salk Institute, 10010 N. Torrey Pines Road, La Jolla, California 92037 Contributed by Renato Dulbecco, December 17, 1979 ABSTRACT A rat mammary cell line (LA7) undergoes profound effect on cultured cells of various types (13, 14). These spontaneous differentiation into domes due to production of effects include stimulation of growth (15), suppression of several specific inducers by the cells. Some of these inducers may be kinds of differentiation and induction of some other lipids, and we show that lipids regulate this differentiation as (16-24), both inducers and inhibitors. One inhibitor is the tumor pro- kinds of differentiation (25-27). TPA also induces a phenotype moter tetradecanoyl-13 phorbol 12-acetate. The inducers are similar to that of transformed cells (28-30), with a reduced saturated fatty acids of two groups: butyric acid and acids with contact inhibition of growth (31), increased production of chain lengths from C13 to C16, especially myristic acid (C14). plasminogen activator (32-35), increased phospholipid turnover Other inducers are myristoyl and palmitoyl lysolecithins, (36-38), decrease of LETS protein (39), and induction of myristic acid methyl ester, and two cationic detergents with a polyamine synthesis (40). TPA may alter the function of the cell tetradecenyl chain. We propose that the lipids with a C14-CI6 plasma membrane, as its alkyl chain affect differentiation by recognizing specific re- suggested by ability to inhibit the ceptors through their alkyl chains and that the effects obtained binding of epidermal growth factor to its receptors at the cell depend on the head groups.
    [Show full text]
  • Report of the 2014 ELA Families / Scientists Meeting
    Report 2014 ELA Families - Scientists meeting April 5 & 6, 2014 Paris, France 2014 ELA FAMILIES – SCIENTISTS MEETING April 5‐6, 2014 Paris, France The 2014 ELA Families/Scientists meeting gathered 360 participants in Paris, among them 27 international scientists with expertise in leukodystrophies and myelin diseases. During the 8 diseases’ workshops and the plenary session organized, scientists presented the results of their research work in lay language and answered questions from patients and their families. This special report compiles the information presented during the scientific workshops. Summary Diseases’ workshops . Workshop on ALD/AMN . Workshop on Refsum disease . Workshop on MLD . Workshop on Krabbe disease . Workshop on CACH/VWM syndrome, Alexander disease, MLC and Canavan disease . Workshop on PMD and other hypomyelinating leukodystrophies . Workshop on undetermined leukodystrophies . Workshop on Aicardi‐Goutières syndrome ‐‐‐ *ALD: AdrenoLeukoDystrophy; AMN: AdrenoMyeloNeuropathy; MLD: Metachromatic Leukodystrophy; CACH/VWM: Childhood Ataxia with Central nervous system Hypomyelination / Vanishing White Matter; MLC: Megalencephalic Leukoencephalopathy with subcortical Cysts; PMD: Pelizaeus‐Merzbacher Disease 2014 ELA Families/Scientists meeting ‐ Report Page 1 DISEASES’ WORKSHOPS WORKSHOP ON ALD/AMN CLINICAL TRIALS EVALUATING THE IMPORTANCE OF STRENGTH ON FUNCTION IN AMN Kathleen Zackowski Ph.D., OTR, MSCS Kennedy Krieger Institute, Baltimore, MD, USA X‐linked adrenoleukodystrophy, a progressive neurodegenerative disease, is caused by a defect in the ABCD1 gene. The disease has multiple subtypes, but the most common form is adrenomyeloneuropathy (AMN). Our previous studies identified the symptoms of the disease in men as slowly progressive spasticity, weakness and sensory dysfunction. The worsening of these symptoms results in the progressive difficulty of walking and of balance problems.
    [Show full text]
  • Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity
    International Journal of Molecular Sciences Review Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity Yannick Das, Daniëlle Swinkels and Myriam Baes * Lab of Cell Metabolism, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, 3000 Leuven, Belgium; [email protected] (Y.D.); [email protected] (D.S.) * Correspondence: [email protected] Abstract: Peroxisomes are multifunctional organelles, well known for their role in cellular lipid homeostasis. Their importance is highlighted by the life-threatening diseases caused by peroxisomal dysfunction. Importantly, most patients suffering from peroxisomal biogenesis disorders, even those with a milder disease course, present with a number of ocular symptoms, including retinopathy. Patients with a selective defect in either peroxisomal α- or β-oxidation or ether lipid synthesis also suffer from vision problems. In this review, we thoroughly discuss the ophthalmological pathology in peroxisomal disorder patients and, where possible, the corresponding animal models, with a special emphasis on the retina. In addition, we attempt to link the observed retinal phenotype to the underlying biochemical alterations. It appears that the retinal pathology is highly variable and the lack of histopathological descriptions in patients hampers the translation of the findings in the mouse models. Furthermore, it becomes clear that there are still large gaps in the current knowledge on the contribution of the different metabolic disturbances to the retinopathy, but branched chain fatty acid accumulation and impaired retinal PUFA homeostasis are likely important factors. Citation: Das, Y.; Swinkels, D.; Baes, Keywords: peroxisome; Zellweger; metabolism; fatty acid; retina M. Peroxisomal Disorders and Their Mouse Models Point to Essential Roles of Peroxisomes for Retinal Integrity.
    [Show full text]
  • Pediatric Multiple Sclerosis
    148 Pediatric Multiple Sclerosis Ji Y. Lee, MD, PhD1 Tanuja Chitnis, MD1 1 Department of Pediatric Neurology, Massachusetts General Hospital, Address for correspondence Tanuja Chitnis, MD, Department of Harvard Medical School, Boston, Massachusetts Pediatric Neurology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit St, ACC708, Boston, MA 02114 Semin Neurol 2016;36:148–153. (e-mail: [email protected]). Abstract Pediatric multiple sclerosis (MS) is a chronic inflammatory neurologic disease that is challenging to diagnose and treat. Although there are many clinical parallels between pediatric-onset MS and adult-onset MS, there is also accumulating evidence of distin- guishing clinical features that may, in part, arise from development-specific, neuro- immune processes governing MS pathogenesis in children. Here the authors describe the clinical features, diagnosis, and treatment of pediatric MS, with a particular focus on describing clinical features and highlighting new developments that promise a better understanding of pediatric MS pathogenesis. An important task that lies ahead for pediatric neurologists is better understanding the early gene–environment interaction Keywords that precipitates the first demyelinating event in pediatric MS. This area is of particular ► multiple sclerosis importance for understanding the MS etiology and the natural history of pediatric MS. ► children Such understanding should in turn inform new developments in diagnostic tools, long- ► demyelination term therapies, and much-needed biomarkers.
    [Show full text]
  • Fatty Acids and Stable Isotope Ratios in Shiitake Mushrooms
    foods Article Fatty Acids and Stable Isotope Ratios in Shiitake Mushrooms (Lentinula edodes) Indicate the Origin of the Cultivation Substrate Used: A Preliminary Case Study in Korea 1, 1, 2 2 3 Ill-Min Chung y, So-Yeon Kim y, Jae-Gu Han , Won-Sik Kong , Mun Yhung Jung and Seung-Hyun Kim 1,* 1 Department of Crop Science, College of Sanghuh Life Science, Konkuk University, Seoul 05029, Korea; [email protected] (I.-M.C.); [email protected] (S.-Y.K.) 2 National Institute of Horticultural and Herbal Science, Rural Development Administration, Eumseong 27709, Korea; [email protected] (J.-G.H.); [email protected] (W.-S.K.) 3 Department of Food Science and Biotechnology, Graduate School, Woosuk University, Wanju-gun 55338, Korea; [email protected] * Correspondence: [email protected]; Tel.: +82-02-2049-6163; Fax: +82-02-455-1044 These authors contributed equally to this study. y Received: 22 July 2020; Accepted: 28 August 2020; Published: 1 September 2020 Abstract: Shiitake mushroom (Lentinula edodes) is commonly consumed worldwide and is cultivated in many farms in Korea using Chinese substrates owing to a lack of knowledge on how to prepare sawdust-based substrate blocks (bag cultivation). Consequently, issues related to the origin of the Korean or Chinese substrate used in shiitake mushrooms produced using bag cultivation have been reported. Here, we investigated differences in fatty acids (FAs) and stable isotope ratios (SIRs) in shiitake mushrooms cultivated using Korean and Chinese substrates under similar conditions (strain, temperature, humidity, etc.) and depending on the harvesting cycle. The total FA level decreased significantly by 5.49 mg g 1 as the harvesting cycle increased (p < 0.0001); however, no differences · − were found in FAs between shiitake mushrooms cultivated using Korean and Chinese substrates.
    [Show full text]
  • Functional Characterization of Novel Mutations in GNPAT and AGPS, Causing Rhizomelic Chondrodysplasia Punctata (RCDP) Types 2 and 3
    RESEARCH ARTICLE OFFICIAL JOURNAL Functional Characterization of Novel Mutations in GNPAT and AGPS, Causing Rhizomelic Chondrodysplasia Punctata www.hgvs.org (RCDP) Types 2 and 3 Brandon Itzkovitz,1† Sarn Jiralerspong,1† Graeme Nimmo,1 Melissa Loscalzo,2 Dafne D. G. Horovitz,3 Ann Snowden,4 Ann Moser,4 Steve Steinberg,4,5 and Nancy Braverman1,6∗ 1Montreal Children’s Hospital Research Institute, Montreal, Quebec, Canada; 2Division of Genetics, Department of Pediatrics, University of South Florida, Tampa, Florida; 3Centro de Genetica Medica, Instituto Fernandes Figueira—FIOCRUZ, Rio de Janeiro, Brazil; 4Department of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland; 5Department of Neurology, Johns Hopkins University, Baltimore, Maryland; 6Department of Human Genetics and Pediatrics, McGill University, Montreal, Quebec, Canada Communicated by Iain McIntosh Received 12 May 2011; accepted revised manuscript 13 September 2011. Published online 3 October 2011 in Wiley Online Library (www.wiley.com/humanmutation).DOI: 10.1002/humu.21623 Introduction ABSTRACT: Rhizomelic chondrodysplasia punctata Rhizomelic chondrodysplasia punctata (RCDP) is a rare disorder (RCDP) is a disorder of peroxisome metabolism result- of ether phospholipid, or plasmalogen, biosynthesis. Patients are ing from a deficiency of plasmalogens, a specialized class suspected clinically by proximal shortening of long bones or rhi- of membrane phospholipids. Classically, patients have a zomelia, bilateral congenital cataracts, dysmorphic facial features, skeletal dysplasia and profound mental retardation, al- and severe growth and developmental delays. Skeletal x-rays show though milder phenotypes are increasingly being iden- punctate epiphyseal calcifications, metaphyseal dysplasia, and ver- tified. It is commonly caused by defects in the peroxi- tebral coronal clefts. Various abnormalities on brain magnetic reso- some transporter, PEX7 (RCDP1), and less frequently nance imaging (MRI) were reported [Bams-Mengerink et al., 2006].
    [Show full text]
  • X Linked Adrenoleukodystrophy: Clinical Presentation, Diagnosis, and Therapy
    4 Journal of Neurology, Neurosurgery, and Psychiatry 1997;63:4–14 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.63.1.4 on 1 July 1997. Downloaded from REVIEW X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy Björn M van Geel, Johanna Assies, RonaldJAWanders, Peter G Barth Abstract that has its onset in adulthood, was first X linked adrenoleukodystrophy (X-ALD) reported in 1976.4 Now, at least six diVerent is an inherited disorder of peroxisomal phenotypes are recognised.5 Not only men are metabolism, biochemically characterised aVected: in the early 1980s it was shown that by accumulation of saturated very long female carriers are at risk for developing chain fatty acids. Accumulation of these neurological deficits as well.6 fatty acids is associated with cerebral In 1976 the accumulation of saturated very demyelination, peripheral nerve abnor- long chain fatty acids (VLCFAs) in brain lipids malities, and adrenocortical and testicu- and adrenal cortex of patients with X-ALD was lar insuYciency. The lowest estimated reported.78 In 1980 raised concentrations of birth incidence is one per 100 000. At least VLCFAs were shown in cultured skin 9 10 six phenotypes can be distinguished, of fibroblasts and in 1981 in plasma, thus Department of which the two most frequent are child- providing a reliable biochemical diagnostic Neurology, Academic hood cerebral ALD and adrenomyelo- test. In 1984 a defect in peroxisomal metabo- Medical Center, 11 neuropathy. The X-ALD gene has been lism was suggested, and shortly thereafter the University of defective enzyme activity in peroxisomal Amsterdam, PO Box identified, but thus far no relation between â-oxidation of VLCFAs was discovered.12 13 In 22700, 1100 DE genotype and phenotype has been found.
    [Show full text]